Evaluating the effect of treatment persistence on the economic burden of moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population

by | May 19, 2019 | Dermatological, immunology, Publication

Abstract Authors: Lee S, Xie L, Wang Y, Vaidya N, Baser O. Background: Psoriasis is a chronic, hyper-proliferative dermatological condition associated with joint symptoms known as psoriatic arthritis (PsA). In a 2013 review, the total economic burden of PsA was...

Analysis of relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate to severe psoriasis using structural equation modeling

by | May 17, 2019 | Dermatological, Publication

Abstract Authors: Lewis-Beck C, Abouzaid S, Xie L, Baser O, Kim E Background: Plaque psoriasis is a chronic disease characterized by scaly plaques on the skin that can itch and bleed. Psoriasis covering over 10% of the body is classified as moderate to severe,...

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

by | May 14, 2019 | Dermatological, immunology, Other Conditions, Publication

Abstract Authors: Knight T, Bond C, Popelar B, Wang L, Niewoehner J, Anastassopoulos K, Philbin M. Background: Dermatomyositis and polymyositis (DM/PM) are rare, incurable inflammatory diseases that cause progressive muscle weakness and can be associated with...